| Patents for C07J 5 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, and substituted in position 21 by only one singly bound oxygen atom (1,937) |
|---|
| 12/27/2002 | WO2002102827A1 PROCESS TO PREPARE 11β, 17α,21-TRIHYDROXY-6α-METHYLPREGNA-1,4-DIENE-3,20-DIONE 21-ACETATE |
| 12/27/2002 | WO2002102826A1 PROCESS TO PREPARE 11β,17α,21-TRIHYDROXY-6α-METHYLPREGNA-1,4-DIENE-3,20-DIONE 21-ACETATE |
| 12/27/2002 | CA2448039A1 Process to prepare 11.beta., 17.alpha.,21-trihydroxy-6.alpha.-methylpregna-1,4-diene-3,20-dione 21-acetate |
| 12/27/2002 | CA2448037A1 Process to prepare 11.beta.,17.alpha.,21-trihydroxy-6.alpha.-methylpregna-1,4-diene-3,20-dione 21-acetate |
| 12/25/2002 | CN1096860C Topical ketoconazole compositions |
| 12/19/2002 | WO2002100878A1 Preparation of flumethasone and its 17-carboxyl androsten analogue |
| 12/19/2002 | WO2002100437A2 Ophthalmic compositions comprising hyaluronic acid |
| 12/19/2002 | CA2449213A1 Ophthalmic compositions comprising hyaluronic acid |
| 12/18/2002 | EP1265911A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 12/11/2002 | CN1095847C New 17,20-epoxy derivatives of pregnane |
| 12/10/2002 | US6492536 Glucocorticoids; antiimflammatory and immunosuppressive agents |
| 11/28/2002 | WO2002094758A1 Methods of making 21-[4'-(nitrooxyalkyl) benzoate] corticosteroid derivatives and intermediates useful in the synthesis thereof |
| 11/20/2002 | EP1163259B1 14.beta.,17-alpha-hydroxymethylandrostane derivatives as androgens |
| 11/14/2002 | WO2002089814A1 17-METHYLENE-ANDROSTAN-3α-OL ANALOGS AS CRH INHIBITORS |
| 11/14/2002 | CA2484596A1 17-methylene-androstan-3alpha-ol analogs as crh inhibitors |
| 11/06/2002 | EP0981349B1 5-alpha-pregnan-3-beta-ol-20-one sulfate for the treatment of tumours and cns diseases |
| 11/05/2002 | US6476012 For therapy of symptomology associated with menopause |
| 10/31/2002 | WO2002051385A8 Solid dispersions of nitrate active principles |
| 10/23/2002 | EP1250927A2 Pharmaceutical composition for topical application comprising nifedipine |
| 10/16/2002 | EP1249238A2 Topical pharmaceutical composition comprising betanechol |
| 10/15/2002 | CA2038985C Haloethyl-substituted steroidal enzyme inhibitors |
| 10/10/2002 | WO2002053577A3 Gabaa modulating neurosteroids |
| 10/10/2002 | US20020147355 Animal extracts; uterine contractions; isolation by distillation, flash chromatography |
| 10/03/2002 | US20020143002 Estradiol-16alpha-carboxylic acid esters as locally active estrogens |
| 09/19/2002 | WO2002036106A3 Novel medicament compositions based on anticholinergics and corticosteroids |
| 09/18/2002 | EP1240179A2 3-methylene steroid derivatives for the treatment of autoimmune diseases |
| 09/18/2002 | EP0823889B1 1,3-propane diol derivatives as bioactive compounds |
| 09/10/2002 | US6448419 Reaction with an organolithium reagent and a boron reagent to form the 2-boronyl intermediate which is then oxidized; anticancer |
| 09/04/2002 | EP1236471A2 Angiostatic steroids |
| 09/04/2002 | EP1236470A2 Angiostatic steroids |
| 09/04/2002 | EP1236469A2 Angiostatic steroids |
| 08/29/2002 | WO2002041925B1 Sterilisation of pharmaceuticals |
| 08/29/2002 | US20020120170 Reducing an alpha-beta-unsaturated ketone to an alpha-hydroxyketone in presence of a catalyst containing manganes complex and a reducing agent |
| 08/20/2002 | US6437157 (20s)(8a,9b,13a,14b,17a) 20-(((dimethylamino)-ethyl)-amino) -19-nor-delta.sup.1,3,5(10)-pregnatrien-3-ol; acylation or alkylation of an estrone, cyanation, oximation; fertility control in males |
| 08/07/2002 | EP1039912B1 Angiostatic agents and compositions for treating glc1a glaucoma |
| 08/01/2002 | WO2002058634A2 ESTRADIOL-16α-CARBOXYLIC ACID ESTERS AS LOCALLY ACTIVE ESTROGENS |
| 08/01/2002 | US20020103392 Corticoid-17,21-dicarboxylic esters and corticosteroid 17-carboxylic ester 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds |
| 07/11/2002 | WO2002053577A2 Gabaa modulating neurosteroids |
| 07/11/2002 | US20020091278 Steroid derived antibiotics |
| 07/04/2002 | WO2002051422A1 Preventives/ermedies for inflammatory airway diseases |
| 07/04/2002 | WO2002051385A1 Solid dispersions of nitrate active principles |
| 07/03/2002 | EP1218014A2 Compositions comprising progesterone or progesterone analogs for the treatment of inflammatory conditions |
| 07/02/2002 | CA2064478C Ophthalmic composition |
| 06/27/2002 | WO2001072293A3 Antiprogestins with partial agonist activity |
| 06/13/2002 | US20020072624 As antiestrogenic and anti-proliferative agent |
| 06/06/2002 | WO2002007683B1 Antimicotic nail varnish composition |
| 05/30/2002 | WO2002041925A1 Sterilisation of pharmaceuticals |
| 05/30/2002 | US20020065256 Antiinflammatory and antiallergic glucocorticosteroid, sterile glucocorticosteroids |
| 05/22/2002 | EP1207165A2 Isomerisation of 6beta-fluorosteroids into the corresponding 6alpha-fluoro derivatives |
| 05/21/2002 | US6392036 Sanitizing particles in sample; obtain sample, expose to heat, monitor sample for antiseptic nature |
| 05/15/2002 | CA2348206A1 Isomerisation of 6beta-fluorosteroids into the corresponding 6alpha-fluoro derivatives |
| 05/10/2002 | WO2002036606A1 Selective glucocorticoid receptor agonists |
| 05/10/2002 | WO2002036106A2 Novel medicament compositions based on anticholinergics and corticosteroids |
| 05/08/2002 | CN1348461A 17 beta-acyl-17 alpha-propynyl-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 05/07/2002 | US6383766 Reduced cortisol conjugates |
| 05/02/2002 | WO2001074840A3 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregna 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 05/02/2002 | WO2001058919A3 Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one |
| 05/02/2002 | WO2001040253A3 3-methylene steroid derivative for the treatment of autoimmune diseases |
| 04/25/2002 | US20020049151 Therapeutic approaches to diseases by suppression of the NURR subfamily of nuclear transcription factors |
| 04/09/2002 | US6369218 Isomerisation of 6β-fluorosteroids into the corresponding 6α-fluoro derivatives |
| 03/28/2002 | WO2002024206A1 Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration |
| 03/28/2002 | CA2422991A1 Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration |
| 02/28/2002 | US20020025951 Urogenital disorders |
| 02/14/2002 | DE10035991A1 Nagellackzusammensetzung Nail polish composition |
| 01/31/2002 | WO2002008243A1 Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid |
| 01/31/2002 | WO2002007683A1 Antimicotic nail varnish composition |
| 01/31/2002 | CA2406963A1 Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid |
| 01/09/2002 | CN1330659A Pregnane glucuronides compound |
| 01/03/2002 | WO2001058919A9 Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one |
| 01/03/2002 | US20020002155 Glucocorticoids; antiimflammatory and immunosuppressive agents |
| 12/27/2001 | WO2001098322A1 Novel steroidal antiestrogens and antiandrogens and uses thereof |
| 12/26/2001 | CN1076607C Process for preparing pharmaceutical composition containing novel steroid esters |
| 12/26/2001 | CN1076606C Use of novel steroid esters for preparing medicaments flammatory and anti-allergic activity |
| 12/20/2001 | WO2001096293A1 Vitamin d derivatives |
| 12/19/2001 | EP1163259A1 14.beta.,17-alpha-hydroxymethylandrostane derivatives as androgens |
| 12/05/2001 | CN1075722C Fungicidal compositions containing bifonazole |
| 11/28/2001 | EP0941361B1 A method for the preparation of steroid compounds |
| 11/22/2001 | WO2001087923A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors |
| 11/22/2001 | CA2408373A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors |
| 11/14/2001 | CN1322210A High purity composition comprising (7a, 17a,)-17-hydroxy-7-methyl 19-nor-17-prege-5-(10)-en-20-yn-3-one |
| 11/08/2001 | US20010039269 Treatment of prostate disorders such as prostatic cancer |
| 10/11/2001 | WO2001074840A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregna 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 10/04/2001 | WO2001072293A2 Antiprogestins with partial agonist activity |
| 10/04/2001 | WO2001022959A3 Compositions comprising progesterone or progesterone analogs for the treatment of inflammatory conditions |
| 10/04/2001 | CA2404172A1 Antiprogestins with partial agonist activity |
| 10/02/2001 | US6297228 Use of angiostatic steroids in photodynamic therapy |
| 09/26/2001 | EP1135403A1 17beta-acyl-17alpha-propynyl-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 09/11/2001 | US6287540 Therapeutic dry powder |
| 08/28/2001 | US6281376 Therapeutic compound—fatty acid conjugates |
| 08/28/2001 | US6281204 19-nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, and the intermediates of this process, their use as medicaments and compositions |
| 08/28/2001 | CA2191324C Process for preparing .delta.9,11 and 21-chloro corticosteroids |
| 08/21/2001 | US6277838 Methods for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
| 08/16/2001 | WO2001058919A2 Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one |
| 08/14/2001 | US6274572 Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds |
| 08/08/2001 | EP1121376A1 Pregnane glucuronides |
| 08/08/2001 | EP1121375A1 High purity composition comprising (7alpha,17alpha)- 17-hydroxy- 7-methyl- 19-nor-17-pregn- 5(10)-en-20-yn-3-one |
| 08/07/2001 | US6271220 Anticancer, antiarthritic agents |
| 07/11/2001 | EP0659080B1 Method for the treatment of hair loss |
| 07/05/2001 | US20010006962 Behavior of biologically active compounds favorably modified by replacing a functional group with an unsaturated fatty derivative, e.g. elaidic acid; bioavailability; membrane passage; organ targeting; drugs; agriculture |
| 06/12/2001 | US6245811 Fatty acid esters as bioactive compounds |